NCT03183245: An ongoing trial by Humacyte, Inc.
This trial is completed, but has been granted a delay in reporting its results.
It must report results 1 year from now.
Full data
| Full entry on ClinicalTrials.gov | NCT03183245 |
|---|---|
| Title | A Phase 3 Study to Compare the Efficacy and Safety of Humacyte's Human Acellular Vessel With That of an Autologous Arteriovenous Fistula in Subjects With End Stage Renal Disease |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Sept. 29, 2017 |
| Completion date | April 22, 2024 |
| Required reporting date | April 22, 2027, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | March 26, 2026 |
| Days late | None |